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Summary
Axonal Kv1 channels regulate action potential propa-
gation—an evolutionarily conserved function impor-
tant for the control of motor behavior as evidenced
from the linkage of human Kv1 channel mutations to
myokymia/episodic ataxia type 1 (EA1) and the Shaker
mutant phenotype in Drosophila. To search for the
machinery that mediates axonal targeting of Kv1 chan-
nels composed of both a and b subunits, we first dem-
onstrate that Kvb2 is responsible for targeting Kv1
channels to the axon. Next, we show that Kvb2 axonal
targeting depends on its ability to associate with the
microtubule (MT) plus-end tracking protein (+TIP)
EB1. Not only do Kvb2 and EB1 move in unison
down the axon, Brefeldin A-sensitive Kv1-containing
vesicles can also be found at microtubule ends near
the cell membrane. In addition, we found that Kvb2
associates with KIF3/kinesin II as well. Indeed, Kv1
channels rely on both KIF3/kinesin II and EB1 for their
axonal targeting.
Introduction
Axonal voltage-gated potassium (Kv1, KCNA, Shaker)
channels control action potential waveform and regulate
the fidelity of action potential propagation (Chiu et al.,
1999; Debanne, 2004; Hodgkin and Huxley, 1952). Multi-
ple Kv1 family members including Kv1.1, Kv1.2, and
Kv1.4, which sharew70% amino acid identity, give rise
to Kv channels in mammalian axons with functions
important for normal behavior and neuronal excitability
(Chiu et al., 1999; Smart et al., 1998). Indeed, mutations
of the human KCNA1 gene cause episodic ataxia type 1
(Browne et al., 1994), most likely due to abnormally ro-
bust action potential invasion of axonal branches of cen-
tral neurons (Herson et al., 2003), as well as hypokalemic
myokymia—a likely consequence of action potential re-
flection (backfiring) from motor nerve terminals (Zhou
et al., 1998). Myokymic and neuromyotonic discharges
of motor axons have also been associated with auto-
antibodies against Kv1 channels in patients with auto-
*Correspondence: lily.jan@ucsf.edu (L.Y.J.), gu.49@osu.edu (C.G.)immune, sometimes paraneoplastic, conditions (Lang
and Vincent, 2003). Intriguingly, Kv1 channel function is
important not only for movement but also for sleep;
Shakerflies are short sleepers (Cirelli et al., 2005). To bet-
ter understand the physiological function and regulation
of Kv1 channels, it will be important to learn how these
channels target to the axon.
In the mammalian brain, Kv1 channels reside in the
axons and terminal fields in multiple brain regions (Mon-
aghan et al., 2001; Southan and Robertson, 2000) and in
cultured neurons (Grosse et al., 2000; Gu et al., 2003).
Their axonal targeting requires the highly conserved
Kv1 T1 tetramerization domain. T1 mutations that disrupt
T1-Kvb interaction abolish the ability of T1 to mediate
axonal targeting (Gu et al., 2003) thus implicating Kvb,
which belongs to the eldo-keto reductase family (Heine-
mann and Hoshi, 2006). These Kvb subunits regulate Kv1
channel inactivation (Rettig et al., 1994) and promote
channel forward trafficking (Shi et al., 1996); however,
it is not known how Kvb might target Kv1 channels to
the axon.
Microtubule (MT)-interacting proteins are good candi-
dates for mediating axonal targeting, since MT extends
down the axon with its plus end pointing distally (Heide-
mann et al., 1981). A number of +TIPs including EB1
specifically track the rapidly growing MT plus end and
concentrate in distal axons and growth cones (Ma
et al., 2004; Zhou et al., 2004). Whether axonal targeting
involves the association of cargos with +TIPs as well as
kinesin, perhaps in a way analogous to protein targeting
to the cell end in yeast (Busch and Brunner, 2004), is an
interesting open question.
Initially identified as a binding partner of the tumor
suppressor adenomatous polyposis coli (APC; Su
et al., 1995), EB1 binds to MT plus end and promotes
MT extension (Akhmanova and Hoogenraad, 2005). The
evolutionarily conserved EB1 contains an N-terminal cal-
ponin homology domain for MT binding (Hayashi and
Ikura, 2003) and a C-terminal domain for dimerization
and for interaction with EB1-binding proteins including
other +TIPs such as APC (Hayashi et al., 2005; Honnappa
et al., 2005; Slep et al., 2005). EB1 can display plus-end
accumulation in the absence of other +TIPs in yeast
(Busch and Brunner, 2004; Busch et al., 2004) and in
mammals (Akhmanova and Hoogenraad, 2005). More-
over, EB1 may enhance kinesin interaction with microtu-
bules (Browning and Hackney, 2005; Galjart, 2005) and
help localizing kinesin to MT plus ends in yeast (Busch
et al., 2004). Similarly, APC, which is transported along
the microtubule via KIF3/kinesin II, may be anchored at
the MT plus end by EB1 in mammalian cells (Akhmanova
and Hoogenraad, 2005).
How membrane proteins such as Kv1 channels are
transported down the axon is an interesting open ques-
tion. Whereas KIF3/kinesin II is involved in the axonal
transport of 90–160 nm vesicles (Yamazaki et al., 1995)
andw40% of these vesicles contain the KIF3-interacting
protein fodrin (Takeda et al., 2000), it is unknown how
most of the cargo vesicles are recognized by KIF3, nor
have the molecular contents of these vesicles been
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804Figure 1. Targeting of Kvb2 to Axons
(A) Hippocampal neurons at 7 DIV were dou-
ble labeled for endogenous Kvb2 (in green)
and dendritic marker MAP2 (in red).
(B) Camera lucida drawing of the neurons in
(A), with dendrites in red and axons in blue.
Kvb2 immunofluorescence measured for 16
segments, the thick lines marked with num-
bers, is given in (C) (mean and standard devi-
ation of fluorescence pixel intensity within the
segment).
(D) Axonal targeting of YFP-Kvb2 (green) was
reduced after treating neurons with 20 nM
Paclitaxel (from 6 hr after transfection to 42
hr after transfection).
(E) Axonal targeting of YFP-Kvb2 was not
affected by treatments with 200 nM Latru
(Latrunculin), 5 nM Jasp (Jasplakinolide), or
100 nM Nocod (Nocodazole). Paclitaxel
(Taxol) treatment significantly reduced the
fraction of transfected neurons with YFP-
Kvb2 enriched by more than 2-fold in axons
compared to dendrites (p < 0.01; one-way
ANOVA followed with Dunnett’s test; in each
of the four experiments conducted, 20–40
transfected neurons were analyzed).
(F) YFP-fusion with wild-type or mutant
(M196A and K235E) Kvb2 each exhibited
enriched YFP fluorescence in axons in over
70% of the neurons analyzed. Four transfec-
tions were performed for each condition.
(G) M196 (in black) and K235 (in blue) of Kvb2
are at the interface of T1 and Kvb2, shown
with helices in red, b sheets in light blue,
and turns in gray. Compared to wild-type
YFP-Kvb2 (H), mutant Kvb2 bearing the
K235E mutation (YFP-K235E, [I]) showed
similar axonal targeting (in green). For this
and following figures, the black background
is converted to white, except for the merged
images.
Arrows, axons. Arrowheads, dendrites. Scale
bars, 100 mm.identified. There is also no precedent for the involvement
of EB1 in axonal targeting of membrane proteins.
In this study, we first showed that axonal targeting of
YFP-Kvb2 was independent of its ability to interact with
Kv1 a subunits, and then identified a novel interaction
between Kvb2 and EB1. Fluorescence resonance energy
transfer (FRET) and live-cell imaging studies further re-
vealed that Kvb2 and EB1 closely associated with each
other as they moved together anterogradely along the
axon. We also identified KIF3/kinesin II as the micro-
tubule-based motor that associates with Kvb2. Finally,
reduction of endogenous EB1 or KIF3 blocked axonal
targeting of Kv1 channels but not voltage-gated sodium
(Nav) channels.
Results
Distribution of Endogenous Kvb2 in Axons
Kvb2 is likely responsible for axonal targeting of Kv1
channels, because mutant T1 domains that cannot
bind Kvb2 (CD4-S40W) could not target the reporter pro-tein CD4 to hippocampal neuronal axons (see Figure S1A
in the Supplemental Data available with this article on-
line; Gu et al., 2003), and Kvb2 appeared at 4 DIV (days
in vitro), before Kv1 channel a subunits could be de-
tected. Consistent with the reported expression pattern
in hippocampal slices (Monaghan et al., 2001), Kvb2
was present in both axonal and somatodendritic regions
at 7 DIV (Figures 1A–1C) and accumulated at the axonal
growth cones (Figure 1A).
Axonal Targeting of YFP-Kvb2 Depends
on Microtubule Dynamics
Similar to endogenous Kvb2, YFP-Kvb2 was found in
axons, especially in distal axons, as well as in the soma-
todendritic region albeit at a lower level (Figure 1H).
Treatment of neurons for 36 hr with the actin depolyme-
rizing agent Latrunculin A (200 nM) or the actin stabilizing
compound Jasplakinolide (5 nM) did not affect axonal
targeting of YFP-Kvb2 (Figure 1E). Because prolonged
exposure of neurons to nocodazole seriously compro-
mised neuronal survival and axonal morphology, it was
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805Figure 2. The K235E Mutant Kvb2 Incapable
of Association with Kv1.2 Has Dominant-
Negative Effect on Kv1.2 Surface Expression
(A) Diagram for FRET between CFP-Kv1.2
and YFP-Kvb2.
(B) Coexpression of CFP-Kv1.2 and YFP-
Kvb2 caused both to appear at cell surface.
In merged image, CFP-Kv1.2 is in blue, YFP-
Kvb2 in green, and FRET in red. Fluorescence
profiles of CFP, YFP, and the robust FRET
signals along the 40 mm white line are shown
in the lower right graph.
(C) No FRET signal was detected between
CFP-Kv1.2 and YFP-K235E. Their inability to
interact is also reflected by the ER localization
of CFP-Kv1.2 and cytosolic pattern of YFP-
K235E. Black arrowhead marks the pseudo
FRET spot due to saturated signal of YFP.
(D–H) Hippocampal neurons transfected at
7 DIV with Kv1.2HA together with YFP (D),
YFP-Kvb2 (E), or YFP-K235E (F), were stained
with anti-HA antibody in unpermeabilized
condition 48 hr later to label surface Kv1.2HA
channels. The staining in (G) was obtained
in permeabilized condition showing total
Kv1.2HA level in the presence of YFP-K235E.
The YFP fluorescence is in green, the surface
anti-HA staining in red. Arrows, axons. Arrow-
heads, dendrites. Scale bars, 100 mm.
(H) The API of Kv1.2HA was increased by
overexpression of wild-type YFP-Kvb2 but
decreased by the K235E mutant YFP-
K235E. The API of each transfected neuron
in nonpermeabilized condition (surface level,
closed bars) or in permeabilized condition
(total level, open bars) equals the average
anti-HA fluorescence intensity in axons nor-
malized by that in dendrites (Faxon/Fdendrite).
The API of each condition is given in mean
and standard error. The APIs of Kv1.2HA in
the presence of YFP were control levels indi-
cated by black (surface) and gray (total) lines.
Student’s t test and one-way ANOVA were
performed for comparing surface and total
API, respectively. Black and gray asterisks in-
dicate the difference from control is statisti-
cally significant. Since YFP-K235E totally
blocked Kv1.2HA surface targeting in both
dendrites and axons, we set its axonal sur-
face polarity index at 0. More than 20 neurons
were measured for each condition.only possible to examine neurons treated with 100 nM
nocodazole, which had no significant effect (Figure 1E).
This low dose of nocodazole may affect microtubule
dynamics (Mimori-Kiyosue et al., 2000); however, in dif-
ferent cell types, this treatment could either increase or
decrease MT catastrophe frequency (Vasquez et al.,
1997). Interestingly, treatment with 10 nM or 20 nM pac-
litaxel, the chemotherapeutic agent that stabilizes micro-
tubule (Rouzier et al., 2005; Tirnauer and Bierer, 2000),
significantly reduced axonal targeting of Kvb2 (Figures
1D and 1E) but not CFP-VAMP2 (Figure S1B), suggesting
that dynamic microtubule growth is important for target-
ing Kvb2 to the axon.
The Critical Role of Kvb2 in Kv1 Channel
Axonal Targeting
To ask whether Kvb2 can target to the axon independent
of its association with the T1 domain of Kv1 a subunits,
we introduced two mutations at the Kvb2-T1 interface(Figure 1G); K235E but not M196A abolished Kvb2 asso-
ciation with T1, while both Kvb2 mutants exhibited nor-
mal axonal targeting (Figures 1F–1I and data not shown).
The inability of YFP-Kvb2 K235E (YFP-K235E) to interact
with CFP-Kv1.2 was evident from live-cell FRET imaging
of HEK293 cells. Whereas wild-type YFP-Kvb2 colocal-
ized and closely associated with CFP-Kv1.2 on the cell
membrane as revealed by the strong FRET signals
(Figure 2B), indicating that they are within 5 nm of each
other (Figure 2A), no FRET signal was detected between
CFP-Kv1.2 and YFP-K235E (Figure 2C). The inability of
CFP-Kv1.2 to interact with the mutant Kvb2 also pre-
vented surface expression (Figure 2C). Taken together,
normal axonal targeting of this Kvb2 mutant (Figures
1F–1I), as well as the early appearance of Kvb2 in hippo-
campal axons (Figure 1A), supports the notion that Kvb2
can independently target to the axon.
Next, we tested the effects of expressing YFP, YFP-
Kvb2, or YFP-K235E on axonal surface expression of
Neuron
806Kv1.2 with an extracellular HA tag (Kv1.2HA). To quantify
the polarized expression, we determined the axonal
polarity index (API), the ratio of average immuno-
fluorescence intensity for major axonal versus dendritic
branches, for both surface expression (surface API)
and total Kv1.2HA protein level (total API). While in
YFP-expressing neurons Kv1.2HA can be sorted to
axon and axonal surface (surface API, 2.47 6 0.24,
n = 32; total API, 0.89 6 0.08, n = 25; Figures 2D and
2H)—probably due to the low level of endogenous
Kvb2 present, overexpression of YFP-Kvb2 dramatically
enhanced Kv1.2HA axonal targeting (surface API, 4.176
0.5, n = 41, p < 0.001; total API, 1.78 6 0.15, n = 27,
p < 0.01; Figures 2E and 2H). Moreover, whereas axonal
targeting of YFP-Kvb2 was observed in about three-
quarters of the neurons (Figure 1F), YFP-Kvb2 Y90A
was enriched in the axons of fewer than 20% of the neu-
rons examined (14.2% 6 2.4%, n = 4, p < 0.0001). Thus,
most likely Kvb2 Y90A competes with endogenous
Kvb2 for Kv1 binding, thereby interfering with Kv1 chan-
nel axonal targeting (Campomanes et al., 2002). Expres-
sion of YFP-K235E also had dominant-negative effects
on Kv1.2HA axonal targeting (surface API, 0, n = 33; total
API, 0.24 6 0.05, n = 20, p < 0.01; Figures 2F–2H). Since
this Kvb2 mutant could not interact with Kv1.2 (Figure 2C)
and yet showed normal axonal targeting on its own (Fig-
ures 1F and 1I), the overexpressed Kvb2 mutant proba-
bly saturated the machinery for Kv1 channel surface
expression as well as axonal targeting, hence reducing
axonal targeting of Kv1.2HA bound to endogenous Kvb2.
Novel Interaction between Kvb2 and EB1,
a Microtubule Plus-End Tracking Protein (+TIP)
What could have targeted Kvb2 to axons and possibly
mediated Kv1 channel axonal targeting? Because Pacli-
taxel, which greatly diminished axonal targeting of Kvb2
(Figures 1D and 1E), compromises MT association with
EB1 (Morrison et al., 1998; Tirnauer and Bierer, 2000),
we tested whether Kvb2 is associated with EB1. Indeed,
we detected EB1 in the complexes brought down by anti-
Kvb2 and anti-Kv1.2 antibodies from rat brain lysates in
our in vivo coimmunoprecipitation (CoIP) experiments
(Figure 3A), revealing that endogenous EB1 is associated
with complexes containing Kv1 channels in the rat brain.
This could reflect either a direct association between
EB1 and Kvb2 or may rather reflect an indirect associa-
tion of these proteins via other proteins in the complex.
To test whether EB1 and Kvb2 can associate with one
another directly, we turned to GST-pull-down assays
and heterologous expression systems. Bacterially ex-
pressed HIS-EB1 brought down Kvb2 expressed in
HEK293 cells (Figure 3B), and bacterially expressed
GST-Kvb2 brought down EB1 from rat brain lysates
(Figure 9A). In addition, when coexpressed in the yeast
Pichia pastoris, mammalian Kvb2 and EB1 were associ-
ated with each other (Figure S2). The interaction was
further confirmed in CoIP studies using HEK293 cells
transfected with Kvb2 together with EB1-GFP (Fig-
ure 3D). These experiments thus reveal a novel interac-
tion between Kvb2 and EB1, likely due to their direct
physical association.
To identify the domain of EB1 that associates with
Kvb2, we fused YFP to either the N- or the C-terminal
domain of EB1, to generate YFP-EB1N and YFP-EB1C(Figure 3C) and found that YFP-EB1C but not YFP-
EB1N coimmunoprecipitated with Kvb2 coexpressed in
HEK293 cells (Figure 3E). The EB1N containing the MT-
binding domain (Hayashi and Ikura, 2003) is connected
via a flexible linker to the EB1C domain that exhibited
association with Kvb2 as well as other +TIPs. Given
that duplication of binding sites due to EB1 dimerization
provides the scaffold for forming macromolecular +TIP
complexes (Hayashi et al., 2005; Honnappa et al., 2005;
Slep et al., 2005), we next explored the potential of EB1
association for MT plus end-directed transport of Kv1
channels to the axon.
Distribution of EB1 and Kv1.2/Kvb2 in Neuronal
Soma and Axons
EB1 expression was already substantial at 3 DIV, with
prominent enrichment at the axonal endings (data not
shown). At 7 DIV, EB1 appeared as punctate structures
in axons; its level in distal axons was twice the level in
proximal axons and dendrites (Figures 3F–3I). Comet-
like EB1 immunoreactivity could also be seen in neurons
and glial cells in the same culture (Figure S3). Our obser-
vations are in agreement with previous studies suggest-
ing that microtubules exhibit dynamic growth all along
the axon (Ma et al., 2004; Stepanova et al., 2003).
Next, we carried out double labeling of EB1 and Kv1.2
in hippocampal neurons. At 14 DIV, when Kv1.2 just be-
came detectable (Grosse et al., 2000; Gu et al., 2003),
EB1 and Kv1.2 partially colocalized in soma and large
axonal endings (Figure 4A); there are also punctate
structures positive for Kv1.2 but not EB1, which could
be Kv1.2-containing vesicles that have reached their
docking sites near the axonal membrane, and ones pos-
itive for EB1 but not Kv1.2, and possibly some low level
of Kv1.2 immunoreactivity on the axonal membrane in
neurons at 14 DIV and 21 DIV (Figures 4A and S4). The
Kv1.2-containing puncta showing partial colocalization
with EB1 (Figures 4B and 4C) were sensitive to Brefeldin
A treatment (Figure 4A) and hence likely post-Golgi
carrier vesicles. Total internal reflection fluorescence
(TIRF) imaging further revealed some of those Kv1.2-
containing puncta at the MT ends near the cell mem-
brane (Figure 4D). Similarly, transfected fibroblasts in
the hippocampal neuronal culture also exhibited MT
association of YFP-Kvb2 and YFP-Kv1.2 near the cell
periphery (Figures S5A and S5B).
Since Kv1 and Kvb coassemble before the a4b4 chan-
nels exit the endoplasmic reticulum (Shi et al., 1996),
those Kv1.2-containing structures that colocalize with
EB1 and are Brefeldin A-sensitive most likely contain
Kvb. Given that the Kvb2 and EB1 antibodies are both
of mouse origin, we verified their partial colocalization
by observing an overlap between EB1-GFP or YFP-
Kvb2 and immunofluorescence for endogenous Kvb2
or EB1, respectively (Figures S5C and S5D).
Kvb2 Mutants with Weakened EB1 Association
and Impaired Axonal Targeting
Next, we tested Kvb2 truncation mutations (Figure 5A) for
EB1 association and axonal targeting. Deleting the last
14 residues (YFP-Kvb2C1) did not affect EB1 interaction
in CoIP assays (Figure 5B) or axonal targeting of this
truncated Kvb2 (Figure 5C). Further deletion of an addi-
tional 15 residues (YFP-Kvb2C2), however, dramatically
EB1 and KIF3 Are Required for Kv1 Axonal Targeting
807Figure 3. EB1 Associates with Kvb2 via Its
C-terminal Domain and Targets to the Axons
of Hippocampal Neurons
(A) EB1 was associated with Kvb2 and Kv1.2
in the rat brain as revealed by in vivo CoIP.
Proteins immunoprecipitated with mouse
control IgG, monoclonal anti-Kvb2, or anti-
Kv1.2 antibodies were resolved with SDS-
PAGE and blotted with anti-EB1 antibody.
Five percent of input was loaded for compar-
ison (right panel).
(B) Purified His-EB1 can pull down Kvb2
expressed in HEK293 cells. The bacterially
expressed His-EB1 was purified with Ni2+
beads and shown with Coomassie staining
in the lower panel (5% of input). The lysates
from HEK293 cells transfected with or without
Kvb2 were incubated with His-EB1 coated
Ni2+ beads. The proteins bound to the His-
EB1-coated beads were resolved with SDS-
PAGE and blotted with anti-Kvb2 antibody
(upper panel).
(C) Diagram of the EB1-YFP, YFP-EB1N, and
YFP-EB1C constructs.
(D) CoIP from transfected HEK293 cells con-
firmed the interaction of Kvb2 and EB1. Im-
munoprecipitation from lysates of HEK293
cells cotransfected with either GFP-Kv1.2
and Kvb2 (left lane), EB1-GFP and Kvb2 (mid-
dle lane), or GFP and Kvb2 (right lane) was
performed using anti-GFP antibody; the blot
was probed with anti-Kvb2 (top panel). Four
percent of inputs were loaded (middle and
lower panels).
(E) CoIP from transfected HEK293 cells re-
vealed that Kvb2 interacts with the C-terminal
region of EB1. Anti-GFP antibody was used
in pull-down. Top panel, the IP blot probed
with anti-Kvb2. Four percent of the inputs
for IP were loaded (middle and lower panels).
Molecular size is indicated on the left of the
blots in kDa. Asterisks, bands corresponding
to full-length GFP or fusion constructs.
(F) Endogenous EB1 preferentially localizes
to distal axons. Cultured hippocampal neu-
rons at 7 DIV were costained with monoclonal
anti-EB1 (in green) and polyclonal anti-MAP2
(in red) antibodies.
(G) The camera lucida drawing of the neurons
in (F) with dendrites in red and axons in
blue. Quantification of EB1 immunofluorescence along 16 thick segments, marked with numbers, is shown in (H) (mean and standard deviation).
The fluorescence intensity for each of these two axons and two dendrites is shown in (I), against the distance from the neuronal soma. Scale
bar, 100 mm.decreased EB1 association (Figure 5B) as well as axonal
targeting (Figure 5C). Moreover, deletion of 90 residues
from the N terminus of Kvb2, which is in the vicinity of
the Kvb2 C terminus structurally (Gulbis et al., 1999),
also disrupted both EB1 association and axonal target-
ing (Figures 5B and 5C).
Visualizing the Interaction of Kvb2 and EB1 in Axons
Using FRET imaging of cultured hippocampal neurons
expressing EB1-YFP and CFP-Kvb2, we found that these
fluorescent fusion proteins were not only both targeted
to distal axons (Figure 6A), there was strong fluores-
cence resonance energy transfer from CFP-Kvb2 to
EB1-YFP in axons (Figure 6C), axonal branches, and
endings (data not shown). Only a small fraction of these
neurons exhibited FRET signals in their soma (Figure 6E).As control, we examined hippocampal neurons express-
ing CFP-Kvb2 and YFP-EB1N, the MT binding domain
that did not associate with Kvb2, and observed no
detectable FRET signals (Figure S6).
Expression of EB1 C-Terminal Domain Interfered
with Axonal Targeting of CFP-Kvb2
Unlike YFP-EB1, YFP fused to the EB1 C-terminal
domain, YFP-EB1C, had dominant-negative effects on
axonal targeting of CFP-Kvb2 (Figure 6B), though they
displayed robust FRET signals in the soma (Figure 6F).
In the rare cases of neurons with barely detectable
axonal CFP-Kvb2, very weak FRET signals could only
be detected in the proximal axons (Figure 6D). This
dominant-negative effect appeared specific for Kvb2,
because YFP-EB1C expression did not impair axonal
Neuron
808Figure 4. Endogenous Kv1.2 and EB1 Colocalized in Hippocampal
Neuron Soma and Axonal Endings at 14 DIV
(A) Neurons double labeled for endogenous Kv1.2 (in green) and EB1
(in red) shown in low magnification (top panels), in high magnifica-
tion for axon ending and soma (middle panels), and for soma after
Brefeldin A treatment (bottom panels). Kv1.2 and EB1 colocalized
in axonal endings and in neuronal soma with double-labeled puncta
(enlarged insets), which disappeared after exposing neurons to
5 mg/ml Brefeldin A for 4 hr before fixation and staining.
(B) Kv1.2 and Kvb2 also colocalized in similar puncta in soma
(enlarged insets).
(C) Of the Kv1.2 positive dots, about half are also positive for EB1
(left; 50.7% 6 3.8%) or Kvb2 (right; 61.2% 6 4.0%). The number of
neurons analyzed is given in white color.
(D) TIRF imaging showing Kv1.2-positive dots (in green) near the
bottom surface of the soma, with some of them on the microtubule
(in red) ends. Shown on top of the merged image is the Kv1.2 immu-
nofluorescence viewed with wide field epifluorescence as in (A) and
(B) and in other figures. The lower panels are some examples of
Kv1.2 and microtubule colocalization at four times higher magnifica-
tion, including the two boxed-areas in merged image (the two upper-
left panels).
Scale bars, 100 mm in the top panels in (A); 20 mm in (B) and third and
fourth rows in (A); 10 mm in (D); 5 mm in the second row in (A). Arrows,
axonal endings. Arrowheads, double-labeled dots in soma.targeting of CFP-VAMP2 (Figure S7A) or the micro-
tubule-associated protein Tau1 (Figure S7B), though
the axons of neurons expressing YFP-EB1C were short-
ened by approximately 50% (Figures S7C and S7D),
similar to the reported effect on dorsal root ganglion
neurons with disrupted EB1 function (Zhou et al., 2004).
Figure 5. Kvb2 Truncations with Weakened EB1 Binding and
Impaired Axonal Targeting
(A) Diagram of YFP fusion with wild-type (YFP-Kvb2) and three Kvb2
truncation mutants, YFP-Kvb2C1, YFP-Kvb2C2, and YFP-Kvb2N.
Green boxes represent YFP and black boxes represent Kvb2 coding
region with the first and last residue number indicated above the
black box.
(B) Kvb2 truncations had weakened EB1 binding. The four Kvb2
fusion proteins were coexpressed with myc-EB1 in HEK293 cells.
Following immunoprecipitation with polyclonal anti-GFP antibody,
the IP blot was probed with anti-myc antibody (upper panel). Lower
panel, 5% of the input was loaded and probed with anti-myc anti-
body. The anti-GFP antibody recognizes YFP, which is derived
from GFP by point mutation.
(C) YFP-Kvb2C1 could still traffic to distal axons, while YFP-Kvb2C2
and YFP-Kvb2N were mainly concentrated in dendrites. The YFP
fluorescence is in green. Dendrites of the neurons were labeled
with anti-MAP2 staining in red. The neurons expressing YFP-
Kvb2C2 and YFP-Kvb2N had normal-looking axons, which could
be seen under the microscope but not in these panels because the
YFP fluorescence in their axons was very weak.
Arrows, axons. Arrowheads, dendrites. Scale bars, 100 mm.
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809Figure 6. FRET Imaging of CFP-Kvb2 and EB1 Constructs Fused
to YFP
Hippocampal neurons were cotransfected with CFP-Kvb2 and EB1-
YFP or YFP-EB1C at 5 DIV. Live-cell FRET imaging was performed
48 hr later.
(A) CFP-Kvb2 and EB1-YFP colocalized in soma and distal axons.
(B) YFP-EB1C and CFP-Kvb2 colocalized mainly in soma but not in
axons. The axonal targeting of CFP-Kvb2 was abolished.
(C) CFP-Kvb2 and EB1-YFP in axons yielded strong FRET signals
(top panels). The merged image is shown in the lower left panel.
Fluorescence profiles of the pixels along the line (10 mm long across
the axon) are shown in the lower middle histogram. Strong FRET
signals (more than 50% of YFP signal) were detected in 19 out of
25 axons (the lower right panel).
(D) Only weak FRET signal between CFP-Kvb2 and YFP-EB1C was
observed in axons (top panels). The left side of the axon segment
was proximal, within 50 mm of the soma. Fluorescence profiles of
the pixels along two lines, a (proximal to soma) and b (distal to
soma) 10 mm long each across the axon segment (shown in the
merged, lower left panel), are shown in the lower middle and right
panels.
(E) In soma, no significant FRET signal was observed between CFP-
Kvb2 and EB1-YFP. The fluorescence profiles of the pixels along the
line (40 mm long across the soma) in the merged image (left panel) are
shown in the middle histogram. Weak but detectable FRET signals
were found in only 3 out of 17 neuronal somas (right panel).YFP-EB1C Exerts Dominant-Negative Effects
on Kv1.2 Targeting to Axonal Surface
Anti-HA antibody staining of unpermeabilized or per-
meabilized neurons expressing Kv1.2HA and Kvb2
together with YFP-EB1C, YFP-EB1N, or EB1-YFP re-
vealed normal polarized Kv1.2HA expression in neurons
expressing EB1-YFP (surface API, 2.70 6 0.25, n = 31;
total API, 1.46 6 0.18, n = 24; Figures 7A and 7D) or
YFP-EB1N (surface API, 2.206 0.3, n = 28, p > 0.05; total
API, 1.316 0.11, n = 22, p > 0.05; Figures 7B and 7D), but
not YFP-EB1C (surface API, 0.406 0.11, n = 35, p < 0.01;
total API, 0.3960.10, n = 20, p < 0.01; Figures 7C and 7D).
The ability of Kv1.2HA to appear on the somatodendritic
but not axonal membranes of most neurons expressing
YFP-EB1C (Figure 7C) is consistent with the notion that
Kvb2 is essential for Kv1 channel surface expression,
whereas Kvb2 interaction with EB1 mediates Kv1 chan-
nel axonal targeting.
Suppressing Endogenous EB1 Level Impairs Kv1
Channel Axonal Targeting
Next, we used a vector-based siRNA strategy to sup-
press endogenous EB1 level (Figures 8A, 8B, and S8).
EB1 knockdown impaired axonal targeting of overex-
pressed Kvb2 (Figure 8C) as well as endogenous Kvb2
(Figure 8D), but not Nav channels (Figure 8F) or Tau1 (Fig-
ures 8G and 8H). Moreover, Kv1.1 antibody staining of
neurons 5 days after transfection with EB1 siRNA (equiv-
alent to 9 DIV) revealed that the endogenous Kv1.1 level
in axons was greatly reduced (Figures 8E and 8H).
EB1-YFP and CFP-Kvb2 Move in Unison
along the Axon
Two-color live-cell imaging further revealed that EB1-
YFP and CFP-Kvb2 colocalized in puncta of different
sizes. Whereas the large puncta tended to be stationary,
the small puncta containing both EB1-YFP and CFP-
Kvb2 moved toward the distal end of the axon (Figure S9).
These mobile particles were not uniform in size, gener-
ally less than 1 mm, and they usually moved for a few mi-
crometers, resembling the EB1 short dashes observed
in cell lines and neurons (Ma et al., 2004; Stepanova
et al., 2003; Figure S9; Movies S1 and S2). For each neu-
ron we imaged, we manually traced the forward move-
ment of individual CFP/YFP double-positive particles
and obtained the average velocity at room temperature
(0.11 6 0.05 mm/s, n = 85), in the same range as EB1
tracking velocity.
Involvement of KIF3 in Kv1 Channel
Axonal Targeting
Compared to the conventional kinesin KIF5/kinesin I,
KIF3/kinesin II moves more slowly (w0.4 mm/sec) and
less processively (average distance of translocation
(F) In soma, robust FRET signals were detected between CFP-Kvb2
and YFP-EB1C. The fluorescence profiles of the pixels along the line
(30 mm long across the soma) in the merged image (left panel) are
shown in the middle histogram. Strong FRET signals (more than
50% of YFP signal) were detected in 22 out of 27 neuronal somas,
while detectable FRET signals were found in only 3 out 25 axons
(the right bar in the histogram).
YFP signal in green, CFP signal in blue and FRET signal in red. Scale
bars, 100 mm.
Neuron
810w4.5 mm; Berezuk and Schroer, 2004). We found that
KIF3/kinesin II is also involved in axonal targeting of
Kv1 channels: first, bacterially expressed GST-Kvb2
pulled down from rat brain lysates not only EB1 but
also KIF3 (Hirokawa and Takemura, 2005; Figure 9A).
Second, when coexpressed in HEK293 cells, Kvb2 coim-
munoprecipitated with KIF3A-GFP, but not KIF5B-GFP
(Figure 9B). Third, endogenous KIF3A was at high levels
in hippocampal neuronal soma, distal axons, and axonal
Figure 7. EB1C Expression Prevents Kv1.2HA Surface Targeting in
Axonal but Not Somatodendritic Region
Cultured hippocampal neurons were cotransfected at 6 DIV, with
Kv1.2HA and Kvb2 plus either EB1-YFP (A), YFP-EB1N (B), or YFP-
EB1C (C), then fixed and stained with anti-HA antibody in unpermea-
bilized condition. YFP fluorescence from these EB1-fusion con-
structs is shown in green in the left column. HA staining revealing
the surface Kv1.2HA level is shown in red in the middle column.
The lower panels are the staining of representative axonal segments
enlarged four times from the upper panels. Scale bars, 100 mm.
Arrows, axons. Arrowheads, dendrites.
(D) Axonal polarity index of surface and total Kv1.2HA was reduced
by coexpressed YFP-EB1C. Hippocampal neurons were cotrans-
fected with Kv1.2HA and Kvb2, together with EB1-YFP, YFP-
EB1N, or YFP-EB1C, then fixed and stained with anti-HA antibody
in either nonpermeabilized (surface, close bars, black line, and
asterisk) and permeabilized (total, open bars, gray line and asterisk)
conditions. The API of each transfected neuron, the average anti-HA
fluorescence intensity in axons normalized by that in dendrites
(Faxon/Fdendrite), was determined in more than 20 neurons for each
combination in each of five independent transfections experiments.
The mean and standard error of API were obtained for each condi-
tion, revealing statistically significant effects of YFP-EB1C on
surface and total API of Kv1.2 (p < 0.01, one-way ANOVA followed
by Dunnett’s test).endings, where it colocalized with EB1 and Kvb2 (Fig-
ure 9C). Finally, we employed siRNA knockdown of
endogenous KIF3A (Figure S10). When transfected into
neuron at 6 DIV, KIF3 siRNA impaired the axonal target-
ing of endogenous Kv1.2 (Figures 9D and 9F) but not
Nav (Figures 9E and 9F) at 17 DIV. Thus, KIF3/kinesin II
is also required for axonal targeting of Kv1 channels.
Discussion
Axonal Kv1 channels of the Shaker family regulate action
potential propagation (Baccus et al., 2000; Chiu et al.,
1999; Debanne, 2004; Hodgkin and Huxley, 1952), a func-
tion important for normal behavior in flies, mice, and
humans (Browne et al., 1994; Herson et al., 2003; Jan
et al., 1977; Smart et al., 1998). It is therefore of great
interest to understand how Kv1 channels target to the
axon.
In this study, we show that Kvb is the Kv1 channel sub-
unit primarily responsible for axonal targeting. We further
identify EB1, the +TIP that binds microtubule via its
N-terminal domain and several other +TIPs via its C-ter-
minal domain (Hayashi et al., 2005; Honnappa et al.,
2005; Slep et al., 2005), as a Kvb2 binding partner crucial
for the axonal transport of Kv1 channels. Finally, we
show that KIF3/kinesin II also associates with Kvb2 and
is required for Kv1 channel axonal targeting:
Kvb2 Is Responsible for Kv1 Channel Axonal
Targeting
Axonal targeting of Kv1 channels likely entails physical
interaction between Kv1 channel subunits and the axo-
nal targeting machinery. We have previously shown
that, when T1 is fused with single span membrane pro-
teins such as CD4 and transferrin receptor, its ability to
promote axonal targeting is abolished by mutations
that prevents its binding to Kvb2 (Gu et al., 2003;
Figure S1A). Together with the finding of Kvb mutations
disrupting Kv1 targeting to axons (Campomanes et al.,
2002), these studies raise the possibility that Kvb sub-
units are responsible for Kv1 channel axonal targeting.
Having found endogenous Kvb2 in the axons of cul-
tured hippocampal neurons within the first week in vitro
(Figures 1A–1C), we next showed that the K235E muta-
tion of Kvb2 at the T1-Kvb2 interface (Figure 1G) elimi-
nated T1 binding (Figure 2C) but did not affect axonal
targeting (Figures 1F–1I and 2F–2H). Whereas YFP-
Kvb2 expression enhanced targeting of Kv1.2HA to the
axonal membrane (Figures 2E and 2H), expression of the
YFP-K235E mutant incapable of assembling with Kv1.2
(Figure 2C) nearly eliminated the surface expression as
well as axonal targeting of Kv1.2HA (Figures 2F–2H).
Taken together, these findings suggest that Kvb2 is
responsible for targeting Kv1 channels to the axon.
The Microtubule Plus-End Tracking Protein EB1
Is Crucial for Kv1 Channel Axonal Targeting
To look for molecules involved in Kv1 channel axonal
targeting, we began by identifying proteins in complex
with Kvb2 in the rat brain. Following up our finding that
YFP-Kvb2 axonal targeting was hampered by paclitaxel
(Figures 1D and 1E), the microtubule stabilizing agent
that also causes EB1 dissociation from microtubules
(Morrison et al., 1998; Tirnauer and Bierer, 2000), we
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(A) EB1 siR2 construct can efficiently suppress the expression of GFP-tagged EB1 in HEK293 cells. HEK293 cells were cotransfected with
EB1-GFP plus control siR, EB1 siR1, or EB1 siR2 in 1:2 cDNA ratio. Three days later, cell lysates were resolved and blotted with anti-EB1,
anti-a-tubulin, and anti-actin antibodies.
(B) EB1 siR2 suppressed endogenous EB1 level in rat hippocampal neurons. Neurons transfected with control siR (upper panels) or EB1 siR2
(lower panels) were compared at low (top panel) and high magnification (bottom panel). GFP fluorescence (in green) is only present in the trans-
fected neurons, while anti-EB1 staining (in red) shows the endogenous EB1 of all neurons in the field.
(C) EB1 siR2 blocks axonal targeting of overexpressed Kvb2. Kvb2 together with either control siR or EB1 siR2 were cotransfected into hippo-
campal neurons. GFP fluorescence (in green) marks the transfected neurons. Anti-Kvb2 staining (in red) is mainly in axons and soma in control
siR-transfected neurons (upper panels) but is restricted in somatodendritic regions in EB1 siR2-transfected neurons (lower panels). EB1 siR2
also dramatically suppressed the axonal staining level of endogenous Kvb2 (red in [D]) and Kv1.1 (red in [E]), but did not significantly affect axonal
staining level of endogenous Nav channels (red in [F]) and Tau1 (red in [G]).
(H) Effects of suppressing EB1 level on axonal targeting of different proteins. For each transfection, more than 20 GFP-positive neurons were
imaged. The percentage of neurons with levels of staining in axons similar to those of control neurons was obtained from three independent
transfections with either control siRNA (black bars) or EB1 siRNA2 (white bars) and is given as means and standard errors. Asterisks indicate
significant differences (p < 0.001).
Arrows, axons or axonal endings. Scale bars, 20 mm in (B), (C), and (F) and 10 mm in (D), (E), and (G).found in CoIP studies association of EB1 with Kv1.2 and
Kvb2 in the rat brain (Figure 3A) and interaction of mam-
malian EB1 and Kvb2 expressed in the yeast Pichia (Fig-
ure S2). Moreover, bacterially expressed His-EB1 pulleddown Kvb2 (Figure 3B) and bacterially expressed GST-
Kvb2 pulled down EB1 (Figure 9A). In addition, Kv1.2
partially colocalized with EB1 in axons of hippocampal
neurons (Figures 4A and 4C). These Kv1.2-containing
Neuron
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(A) Both KIF3A and EB1 from rat brain can be pulled down by purified
GST-Kvb2. GST-Kvb2 was expressed in E. coli, purified with gluta-
thione beads (lower panel), and then incubated with rat brain lysates.
The elution was resolved and blotted with anti-KIF3A (upper panels)
and anti-EB1 antibodies (middle panels). GST was the negative
control. Five percent of input was loaded for comparison.
(B) KIF3A-GFP but not KIF5B-GFP coimmunoprecipitated Kvb2.
Upper panels are the diagrams of KIF3A-GFP and KIF5B-GFP con-
structs. KIF3A-GFP and Kvb2 (left), KIF5B-GFP and Kvb2 (middle),
or EB1-GFP and Kvb2 (right) were coexpressed in HEK293 cells.
The CoIP assay was performed using anti-GFP antibody; the blot
was probed with anti-Kvb2 antibody (upper panel). Four percent of
inputs were loaded (lower panel).
(C) Endogenous KIF3A colocalizes with EB1 and Kvb2 in axons. In-
sets show the axonal ending of another neuron in high magnification.
(D) Suppressing KIF3A with siRNA impairs Kv1.2 axonal targeting.
Neurons transfected with either control siR plasmid (upper panels)
or KIF3A siR2 plasmid (lower panels) together with GFP at 6 DIV,
were stained for endogenous Kv1.2 at 17 DIV.
(E) KIF3A knockdown did not alter Nav channel axonal targeting.
Immunocytochemical signals are inverted, showing similar Nav
channel targeting to axons (arrows) in control (top) and KIF3A siRNA
(bottom) at 16 DIV.
(F) For each siRNA transfection experiment, more than 20 GFP-pos-
itive neurons were imaged. The percentage of neurons with levels of
staining in axons similar to those in control neurons was obtained
from three independent transfections with either control siRNApuncta, likely post-Golgi carrier vesicles given their sen-
sitivity to Brefeldin A (Figure 4A), could be found at the
MT ends near the cell membrane of neuronal soma
(Figure 4D), as expected from their partial colocalization
with EB1. Given the ability of EB1 to track the plus ends
of growing microtubules while they extend distally in
the axons (Ma et al., 2004; Nakata and Hirokawa, 2003;
Stepanova et al., 2003), its association with Kv1 channel
subunits in central neurons raises the intriguing question
concerning the role of EB1 in Kv1 channel axonal
targeting.
We have obtained several lines of evidence implicating
EB1 in axonal targeting of Kv1 channels. First, there was
excellent correlation between the ability of truncation
mutants of Kvb2 to associate with EB1 and their axonal
targeting (Figures 5A–5C). Second, expression of a fluo-
rescent fusion protein of EB1 C-terminal domain (YFP-
EB1C) had dominant-negative effects over Kv1 channel
axonal targeting (Figures 6 and 7). Finally, suppressing
EB1 level via siRNA impaired the axonal targeting of
endogenous Kv1.1/Kvb2 (Figures 8D and 8E), but not
Nav channels and Tau1 (Figures 8F–8H). Taken together,
these findings strongly suggest that EB1 is crucial for
Kv1 channel axonal targeting. In future studies, it would
be of interest to find out whether other +TIPs are involved
in axonal targeting of Kv1 or other ion channels.
A Hypothesis for How EB1 and KIF3/Kinesin II
Mediate Kv1 Channel Axonal Targeting
How might axonal targeting of Kv1 channels be depen-
dent on EB1? After assembly of Kv1.2 and Kvb2 in the
endoplasmic reticulum (Misonou and Trimmer, 2004),
both endogenous channel subunits colocalize in puncta
(Figures 4B and 4C) much the same way as Kv1.2 locali-
zation to the EB1-positive puncta (Figures 4A and 4C),
presumably due to the association of EB1 with com-
plexes of Kv1.2/Kvb2 in post-Golgi carrier vesicles. Our
finding thus lends further support to the notion that the
punctate distribution of endogenous EB1 could reflect
EB1 association with vesicles or large protein complexes
(Vaughan, 2005). Whereas our two-color live-cell imag-
ing showed anterograde comigration of Kvb2 and
EB1 along axons (Figure S9A), at the rate of 0.11 6 0.05
mm/s at room temperature, reasonably comparable to
the rate of EB1-GFP movement (w0.2 mm/s at 37C;
Stepanova et al., 2003), it is important to note that the
involvement of EB1 in Kv1 channel axonal targeting
does not preclude a likely role of MT-based motors in
axonal transport of Kv1 channels or the involvement of
other +TIPs. Indeed, we have found interactions be-
tween Kvb2 and KIF3/kinesin II and a requirement of
KIF3 for axonal targeting of endogenous Kv1 channels
but not Nav channels (Figures 9 and S10).
How could Kv1 channel axonal targeting be depen-
dent on both EB1 and KIF3/kinesin II? Our findings indi-
cate that the KIF3/kinesin II motor coimmunoprecipi-
tated with Kvb2, suggesting that KIF3 either interacts
(black bars) or KIF3A siRNA2 (white bars) and is given as means
and standard errors for Kv1.2 (left) and Nav (right) channels. Aster-
isks indicate significant differences (p < 0.001).
Arrows and arrowheads, axons. Scale bars, 100 mm in (C), 60 mm in
(D) and (E), and 10 mm in (C) insets.
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813directly with Kvb2 or at least that the two proteins are
associated in a complex and that KIF3 is required for
targeting of Kv1.2. Given that a vesicle may contain
multiple Kv1 channels each of which containing four
Kvb2 subunits, the same vesicle may be associated
with both EB1 and KIF3, which moves at about twice
the rate of EB1 tracking at the plus end of microtubules
(Ma et al., 2004; Nakata and Hirokawa, 2003; Stepanova
et al., 2003). Given the presence of bundles of micro-
tubules with their growing plus ends pointing distally
but distributed all along the axon, interaction between
Kvb2 and EB1 as well as KIF3 may enhance the ability
of Kv1-containing vesicles to stay associated with mi-
crotubules—with ends of microtubule presumably via
EB1 (Figure 4D) and with microtubules via the KIF3
motor. The ability of Kvb2 subunits of the Kv1 channel
to associate with the dimeric EB1 and the trimeric KIF3,
which contains two motor proteins KIF3A and KIF3B,
may further enhance the interaction between these
proteins and microtubules, analogous to the ability of
the yeast EB1 and kinesin—both dimeric proteins that
associate with each other—to mutually stabilize their
interactions with microtubules (Browning and Hackney,
2005; Galjart, 2005), and the ability of EB1 and EB3 to
mediate CLIP protein accumulation at the MT tips
(Komarova et al., 2005). In addition, as the KIF3-driven
vesicle containing Kv1 channels reaches the MT plus
end, its association with EB1, which promotes MT exten-
sion, may either allow the vesicle to hold onto the micro-
tubule plus end before shifting to another microtubule in
the bundle or—if the MT plus end is within reach of the
axonal membrane, to facilitate vesicle delivery to the
axonal membrane.
Interaction between the Evolutionarily Conserved
EB1, Kvb, and KIF3/kinesin II Provides a Novel
Mechanism for Axonal Targeting
Kvb and its interacting proteins EB1 and KIF3/kinesin II
are evolutionarily conserved; human EB1 when intro-
duced to Xenopus egg extracts promotes MT extension
and decreases catastrophe rates (Tirnauer et al., 2002),
and it partially rescues the loss-of-function phenotype
for the fission yeast homolog of EB1 (Browning et al.,
2003). Given that in Drosophila melanogaster the hypo-
morphic DmEB1 mutants show neuromuscular defects,
including uncoordinated movements and inability to fly
(Elliott et al., 2005), it would be of great interest to further
determine whether the Kvb/EB1 interaction is evolution-
arily conserved and whether kinesin II is required for
Kv1 channel axonal targeting in both vertebrates and
invertebrates.
In both central and peripheral nervous system, Kv1
channels are targeted to discrete domains of myelinated
axons, the juxtaparanodal regions (Rhodes et al., 1997).
Given the important role of Kv1 channels in regulating
axonal conduction of action potentials (Chiu et al.,
1999; Debanne, 2004; Herson et al., 2003; Hodgkin and
Huxley, 1952), understanding the molecular mechanism
underlying axonal targeting of these channel proteins not
only will help us appreciate how Kv1 channel density in
various regions of the axonal membrane could be
modulated, it could also prove valuable to efforts aimed
at designing treatments of axon demyelination and
degeneration diseases, such as multiple sclerosis.Experimental Procedures
Materials
Reagents used include rabbit anti-MAP2 and anti-Tau1 antibodies
(Chemicon), Phalliodin Alexa 680 (Molecular Probes), rat monoclonal
anti-HA antibody (Roche), rabbit anti-EGFP antibody (a kind gift from
Dr. Yang Hong), mouse anti-Kvb2, anti-Kv1.1, anti-Kv1.2 (Upstate
Biotechnology and Antibodies Inc.), rabbit anti-Kv1.2 antibody
(Alomone labs), mouse anti-EB1 antibody (BD Transduction Labora-
tories), rabbit anti-pan-Nav channel antibody (a kind gift from Dr. S.
Rock Levinson), mouse anti-a-tubulin, anti-a-actin, and anti-pan-
Nav channel antibodies (Sigma), rabbit anti-KIF3A antibody (Abcam),
Cy2, Cy3, and Cy5 conjugated secondary antibodies (Jackson
Laboratory), Latrunculin A, Jasplakinolide, and Brefeldin A (Calbio-
chem), Nocodazole and Paclitaxel (Sigma), EB1-GFP (a kind gift
from Dr. Michelle Piehl), VAMP2 (a kind gift from Dr. Richard Schel-
ler), KIF5B (a kind gift from Dr. Ron Vale), and KIF3A (Invitrogen).
cDNA Constructs
YFP-Kvb2 and CFP-Kvb2 were constructed by inserting the coding
sequence of Kvb2 into pEYFP-C1 or pECFP-C1 (Clontech) between
EcoRI and SalI sites. CFP-Kv1.2 and YFP-Kv1.2 were constructed
by inserting the coding sequence of Kv1.2 into pECFP-C1 and
pEYFP-C1, respectively, between BglII and SalI sites. Kv1.2HA was
described previously (Gu et al., 2003). EB1-YFP, EB1-CFP, and His-
EB1 were constructed by inserting the coding sequence of EB1
into pEYFP-N1, pECFP-N1, and pRSET B, respectively, between
BglII and HindIII. YFP-EB1N and YFP-EB1C were constructed by
inserting EB1 cDNAs encoding residue 1–181 and 197–268 into
pEYFP-C1, respectively, between BglII and HindIII. YFP-Kvb2C1,
YFP-Kvb2C2, and YFP-Kvb2N were constructed by inserting Kvb2
cDNA encoding residue 1–353, 1–338, and 91–367 into pEYFP-C1, re-
spectively, between EcoRI and SalI. Myc-EB1 was constructed by
inserting the coding sequence of EB1 into pRK5 between SalI and
NotI. CFP-VAMP2 was constructed by inserting the coding region
of VAMP2 to pECFP-C1 between BglII and EcoRI.
KIF3A-GFP and KIF5-GFP was constructed by inserting the coding
regions of KIF3A and KIF5 to pEGFP-N1 between EcoRI and SalI.
These constructs were verified with restriction enzyme digestion
and sequencing.
Structure-Based Mutagenesis
By employing the UCSF Chimera program, we designed two point
mutations on Kvb2 at the Kvb2-T1 interface, M196A (Met at position
196 mutated to Ala) and K235E (Lys at position 235 mutated to Glu),
used Quickchange strategy based upon the YFP-Kvb2 construct to
generate the mutations, and verified them by sequencing.
Hippocampal Neuron Culture and Transfection
Hippocampal neuron culture was prepared as previously described
(Gu et al., 2003). In brief, 2 days after neuron plating, 1 mM cytosine
arabinose was added to the neuronal culture medium to inhibit glial
growth for the subsequent 2 days, then replaced with normal neuro-
nal culture medium, replenished twice a week by replacing half with
the fresh. For transient transfection, neurons in culture at 5 to 7 DIV
were incubated in Opti-MEM containing 0.8 mg cDNA plasmid and
1.5 ml Lipofectamine 2000 (Invitrogen) for 30 min at 37C.
Coimmunoprecipitation, Protein Purification
and Western Blotting
Rat brain or HEK293 cells transfected with various constructs were
homogenized and solubilized in IP buffer (50 mM Tris-HCl [pH 7.4],
150 mM NaCl, 1% Triton X100, and complete protease inhibitor tablet
[Roche]) for 2 hr at 4C, then centrifuged at 20,800 3 g for 30 min at
4C. The supernatant was incubated (2–4 hr, 4C) either with mouse
anti-Kvb2 antibody and protein G agarose beads (Roche) or with
rabbit anti-GFP antibody and protein A agarose beads (Invitrogen).
The beads were washed six times with IP buffer and eluted with
23 sample buffer. The coimmunoprecipitates were resolved by
SDS-PAGE, transferred to a PVDF membrane, and subjected to
western blotting. The His-tagged EB1 (His-EB1) was expressed in
BL21 cells induced by 1 mM IPTG for 4 hr at 37C, solubilized in IP
buffer with sonication at 4C, centrifuged at 20,800 3 g for 30 min
at 4C, then purified with Talon Ni2+ resin (Clontech). These resin
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814beads coated with purified His-EB1 were either eluted with Imidaz-
ole-containing IP buffer or directly used for pull-down experiments
with HEK293 cell lysates. Similarly, the GST-tagged Kvb2 (GST-
Kvb2) was purified with glutathione beads (Amersham) and incu-
bated with rat brain lysates for pull-down of interacting proteins.
Immunocytochemistry and Fluorescence Microscopy
As described previously (Gu et al., 2003), neurons were permeabi-
lized right after fixation for labeling the endogenous proteins and
Kv1.2HA total proteins, whereas Kv1.2HA surface expression was
revealed by labeling neurons with anti-HA antibody in nonpermeabi-
lized condition after fixation. Fluorescence images were captured
with Spot CCD camera RT slider (Diagnostic Instrument Inc.) in
a Nikon upright microscope Eclipse E800 using Plan Apo objective
203/0.75, 603/1.4 oil, or 1003/1.4 oil, saved as 16-bit TIFF files,
and analyzed with NIH Image J and Sigmaplot 8.0 for fluorescence
intensity quantification. Exposure times were controlled so that the
pixel intensities in dendrites and axons were below saturation, but
the same exposure time was used within each group of experiment.
Only transfected neurons with separated dendrites and axons and
which were isolated from other transfected cells were chosen for
analysis. The detailed quantification procedure is in Supplemental
Data.
siRNA Suppression of Endogenous EB1 and KIF3A
Expression in Neurons
We used vector-based siRNA strategy to suppress the endogenous
EB1 level in rat hippocampal neurons. Three 21 nucleotide se-
quences unique to rat EB1 were selected from the open reading
frame, nucleotides 10–30 (EB1 siR1), nucleotides 62–82 (EB1 siR2),
and nucleotides 221–241 (EB1 siR3). For constructing each siRNA
construct, two complementary strands of DNA, from 50 to 30, contain-
ing a BamH1 site, 21 nucleotide antisense, loop (TTGATATCCG), 21
nucleotide sense, and a HindIII site, were chemically synthesized and
inserted into the BamHI/HindIII sites of pRNAT-H1.1/neo vector
(GenScript), which also contains a GFP gene. EB1 siR2 (nucleotides
62–82, CAATGAATCTCTGCAGTTGAA) can efficiently suppress ex-
pression of EB1 in rat hippocampal neurons, as well as human EB1
with only one nucleotide difference in this region, while negative con-
trols, one kindly provided by Dr. Z.H. Sheng and one scrambled EB1
siR2, had no effect on EB1 expression. The plasmids were usually
transfected into hippocampal neurons with Lipofectamine 2000 (Invi-
trogen) at 4 DIV, and neurons were fixed and stained 3 days later. GFP
fluorescence signal indicated the transfected neurons. As control,
we cotransfected siRNA plasmids with EB1-GFP into HEK293 cells
in 2:1 ratio. Three days later, the cells were lysed and resolved with
SDS-PAGE and subsequentially blotted with anti-EB1, anti-a-tubu-
lin, and anti-actin antibodies. The same strategy was used to gener-
ate KIF3A siRNA. From NCBI website, we found a cDNA sequence
(accession number AF155825) containing the second half of rat
KIF3A. Three siRNA probes were designed based upon this se-
quence. KIF3A siR2 (CAAGGAAAGACCAAGAAATTA) can efficiently
suppress endogenous KIF3A level in rat neurons, while controls
had no effect.
Live-Cell Time Lapse and FRET Imaging
Cultured neurons or HEK293 cells were plated onto 22 mm round
glass coverslips (Fisher) and mounted to an imaging open chamber
(Brook Industries) covered with Hank’s buffer (20 mM HEPES
[pH 7.2], 150 mM NaCl, 24 mM KCl, 1 mM MgCl2, 1 mM CaCl2,
10 mg/ml glucose). All experiments were performed in room temper-
ature. The live-cell FRET imaging system consists an inverted micro-
scope Nikon Eclipse 300, a black/white camera, SensiCam (The
Cooke Corporation), and filter wheels (Sutter) with filters and control-
ler LAMBDA 10-2 (Sutter) for both excitation and emission. Image
captures and rapid switch of filters in both excitation and emission
sides were achieved through Image-Pro Plus program (Media Cyber-
netics), allowing FRET measurement between CFP and YFP. For
two-color time lapse imaging, only YFP and CFP filter channels
were used. The bleedthrough across the YFP and CFP channels is
less than 1% in our setup, and the fluorescence intensities of EB1-
YFP and CFP-Kvb2 were similar, so the contribution of bleedthrough
to our signals is minimal. For each series, 30 images were captured
with 5 s interval. The CFP/YFP-positive particles moving anterog-radely along axons were manually traced. The velocity of these
moving particles was measured for a total of 85 particles from 18
neurons and then averaged. The strategy and protocol of FRET imag-
ing were described previously (Gu et al., 2001; Sorkin et al., 2000). In
brief, three images were acquired sequentially through (1) CFP filter
set (excitation 430/25 nm, emission 470/30 nm); (2) YFP filter set
(excitation 500/20 nm, emission 535/30 nm); (3) FRET filter set (exci-
tation 430/25 nm, emission 535/30 nm). A single dichroic mirror
(86004BS; Chroma) was used with all three filter channels. FRET
between CFP and YFP was measured and calculated for the entire
image on a pixel-by-pixel basis by a three-filter ‘‘microFRET’’
method. The raw FRET images consisted of both FRET and non-
FRET components (the donor and acceptor fluorescence bleeding
through the FRET filter). The extent of crossbleeding was character-
istic of the particular optical system and determined by the use of
cells that express either CFP or YFP alone. In our system, 60.3% 6
1.5% (n = 6) of CFP, and 23.6% 6 0.8% (n = 6) of YFP fluorescence
can bleed through the FRET channel. Therefore, to ensure our im-
ages contain no bleedthrough components, we subtracted the raw
FRET image with CFP image multiplied by 0.65 and YFP image
multiplied by 0.25. All calculations for images were performed after
subtraction of the background fluorescence values.
TIRF Imaging
TIRF imaging was done using a Nikon TE-2000E inverted micro-
scope with a 603 1.45 NA TIRF objective (Nikon), equipped for
through-the-objective TIRF microscopy. A 488 nm Argon-ion laser
(Melles Griot) and a 543 nm HeNe laser (Spectra Physics) were
used as light sources. The laser output was transmitted through a
fiber optic cable, the position of which was adjusted using a micro-
meter to focus the beam off-axis at the back focal plane at an angle
greater than 61 to generate the evanescent wave. Images were
acquired using a C9100-12 EM-CCD camera (Hamamatsu Photon-
ics) driven by IPLab (Scanalytics).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/5/803/DC1/.
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